painreform.com (PRFX): Net earnings per share growth forecast for next year
The stability of PainReform Ltd. (PRFX) is based on the robotization of analgesic filling lines, which confirms the consensus earnings per share trend on the GURU.Markets temporary chart, where the 0.00 level reflects the current value. The operational base relies on zero-waste substance synthesis and a high dependence of capitalization on regulatory approval for one key pain relief drug.
PRFX (painreform.com): analytical breakdowns and indicator data
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
Total Debt to Capital PainReform Ltd.|PRFX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity PainReform|PRFX - Company Aggregate Debt|Debt to Book Capitalization Ratio PainReform|PRFX - Company Long-Term Loans and Borrowings|Company Short-Term Debts PainReform|Quick Ratio painreform.com
- net income and valuation ratios data:
PRFX - Profit After Tax|Expected Profit PainReform Ltd.|PRFX - Market Cap to Earnings|Future Price to Earnings PainReform Ltd.|PRFX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PainReform|PRFX - Operating profit before deduction of amortization|Net earnings per share for the last 12 months PainReform|PRFX - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months painreform.com|PRFX - Earnings per share growth in current year|Expected earnings per share growth for next year PainReform Ltd.
General company analysis:PRFX, PainReform Limited
PainReform Ltd. specializes in the development of analgesics, outsourcing production and clinical trials to third-party contractors, which renders its profit sensitive to the operational efficiency of its vendors. This consensus on next year's earnings per share reflects aggregate analyst expectations regarding EPS dynamics, allowing investors to assess the resilience of the business model by analyzing forecast revisions on the chart.
Competitor analysis for PainReform Ltd.
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand LGND|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share change forecast for next year|Perrigo Company - Earnings growth forecast for next year|ALVO - Earnings growth forecast for next year|LQDA: Earnings growth forecast for next year|GLPG - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year ANI Pharmaceuticals, Inc.|Projected earnings per share growth rate for next year MNKD (MannKind Corp)|Net earnings per share growth forecast for next year Amphastar (AMPH)|PCRX (Pacira Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year SPRY (ARS Pharmaceuticals)|theravance.com (TBPH) - Expected net earnings per share growth next year|Aquestive Therapeutics, Inc. - Earnings growth forecast for next year|Net earnings per share change forecast for next year SCPH|tectonictx.com (TECX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Tonix Pharmaceuticals Holding (TNXP)|Net earnings per share growth forecast for next year SXT Pharmaceuticals|EPRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioHarvest Sciences Inc. (BHST)|Expected earnings per share growth for next year Invizyne Technologies EXOZ|Oramed Pharmaceuticals Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year ENTX|HYFT - Net earnings per share growth forecast for next year|ABVC: Net earnings per share growth forecast for next year|CPIX (Cumberland Pharmaceuticals Inc.) - Expected earnings per share growth for next year|QNTM: Projected earnings per share increase next year|FGEN (FibroGen Corp) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year TELO (Telomir Pharmaceuticals Corp)|Expected earnings per share growth for next year RANI (Rani Therapeutics)|Consensus forecast of earnings per share growth for next year synergychc.com|Net earnings per share growth forecast for next year Rallybio RLYB|LEXX (Lexaria Bioscience Corp) - Net earnings per share change forecast for next year|PULM - Net earnings per share growth forecast for next year|Expected earnings per share trend next year PTHL (Pheton Holdings Ltd)|APM: Earnings growth forecast for next year|Net earnings per share change forecast for next year LYRA (lyratherapeutics.com)|Expected earnings per share growth for next year IBO|Projected earnings per share growth rate for next year TNFA (TNF Pharma)|Net earnings per share growth forecast for next year cbdMD, Inc. (YCBD)|CYTO: Net earnings per share change forecast for next year|Earnings growth forecast for next year LIPO (Lipella Pharmaceuticals)|Expected earnings per share trend next year OPTN|Pieris Pharmaceuticals, Inc. - Earnings growth forecast for next year|PROC - Earnings growth forecast for next year|Petros (PTPI) - Net earnings per share growth forecast for next year|Qilian International Corp - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Acelyrin, Inc.|Expected earnings per share growth for next year tffpharma.com (TFFP)
